Horizon Therapeutics Public Lim Price Today
Horizon Therapeutics Public Lim
HZNP
Healthcare
$22.92B
๐ฐ
Market Cap
63.4
๐ธ
Price to Earnings
$1.6
๐
EPS
+0
๐ณ
ESG
Consensus Recommendations
Hold Consensus
Buy |
3 |
Strong Buy |
3 |
Hold |
7 |
Sell |
0 |
Strong Sell |
0 |
HZNP Price Forecast Target
100.1 ๐ 116.5 +16%
HZNP EPS Forecast
1.6 ๐ 6.8 +328%
Financials
Profit Margin
10 %
Revenue Growth
-6.0 %
Dividend
$ 0
Held Percent
1.2% - Insiders
100.9% - Institutions
-2.1% - Public
Major Fund Holders
-
๐ฐ Vanguard Group Inc $2.4B
-
๐ฐ Blackrock Inc. $1.6B
-
๐ฐ Avoro Capital Advisors LLC $764.0M
-
๐ฐ Pentwater Capital Management Lp $665.8M
-
๐ฐ JP Morgan Chase & Company $598.8M
Stock Ideas
Jim Chanos Portfolio
Jim Chanos is a revered figure in the world of portfolio management, known for his expertise in short selling and his pivotal role in uncovering fraud at Enron and WorldCom. Hailing from Milwaukee and a graduate of Yale with an economics degree, ChโฆElon Musk Portfolio
Enter the visionary world of Elon Musk, a name that needs no introduction in the realms of innovation, entrepreneurship, and technology. With a trailblazing spirit and an unyielding drive, Musk has become a household name, propelling himself to extrโฆBruce Berkowitz Portfolio
Bruce Berkowitz, the esteemed founder of Fairholme, has established himself as a prominent figure in the investment world with his exceptional portfolio strategy. Since its inception in 1999, Fairholme has grown into a formidable $19 billion mutual โฆDavid Shaw Portfolio
David Shaw is a renowned computer scientist, technological pioneer, and founder of D.E. Shaw Group, one of the earliest quantitative hedge funds. Shaw pioneered the use of algorithmic and computational modeling in institutional investing. While littโฆ๐ฎFAQ
Some Frequently Asked Questions.
The Horizon Therapeutics Public Lim industry is Drug ManufacturersโGeneral
The Horizon Therapeutics Public Lim sector is Healthcare
The Horizon Therapeutics Public Lim forecasted predicted Price to Earnings PE ratio is 14.8
The Horizon Therapeutics Public Lim Price to Earnings PE ratio is 63.4
The Market Capitalization of Horizon Therapeutics Public Lim is $22.92B
There are total of 223596695 float shares with 100.9% held by Institutions and 1.2% held by insiders
The MHorizon Therapeutics Public Lim forecasted Earnings per Share EPS is $6.8
The Horizon Therapeutics Public Lim Earnings per Share EPS is 1.6
The Horizon Therapeutics Public Lim company has $2800556000 gross profits with 10 profit margins
The Horizon Therapeutics Public Lim Earnings Growth is -0.736% with -0.732% quarterly earnings growth
The Horizon Therapeutics Public Lim Revenue is $3575857920 with -0.06 revenue growth
The price target for Horizon Therapeutics Public Lim stock is $116.5 for the high target and $116.5 for the low target
The consensus analyst recommendations for Horizon Therapeutics Public Lim is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Horizon Therapeutics Public Lim is Hold, with the following breakdown:
- Buy: 3
- Strong Buy: 3
- Hold: 7
- Sell: 0
- Strong Sell: 0
The Beta of Horizon Therapeutics Public Lim is 1.1
The dividend of Horizon Therapeutics Public Lim is $0
The dividend yield of Horizon Therapeutics Public Lim is 0%
The biggest institutional and mutual fund holders of Horizon Therapeutics Public Lim stock are
- Vanguard Group Inc
- Blackrock Inc.
- Avoro Capital Advisors LLC
- Pentwater Capital Management Lp
The Horizon Therapeutics Public Lim ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0